Skip to main content
. 2023 Apr 24;10(4):370–380. doi: 10.1093/nop/npad022

Figure 1.

Figure 1.

Oncoprint analysis of patients identified to have a targetable fusion protein. Tumors are grouped from most frequently to least frequently seen fusion, with age, sex, and diagnosis indicated at the top.